News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,570 Results
Type
Article (49854)
Company Profile (278)
Press Release (685438)
Multimedia
Podcasts (60)
Webinars (12)
Section
Business (212303)
Career Advice (2098)
Deals (36534)
Drug Delivery (104)
Drug Development (83637)
Employer Resources (173)
FDA (16975)
Job Trends (15719)
News (359295)
Policy (34691)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2782)
Accelerated approval (5)
Adcomms (23)
Allergies (85)
Alliances (51594)
ALS (91)
Alzheimer's disease (1432)
Antibody-drug conjugate (ADC) (125)
Approvals (16976)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (16)
Bankruptcy (373)
Best Places to Work (12099)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (191)
Bladder cancer (65)
Brain cancer (27)
Breast cancer (282)
Cancer (2194)
Cardiovascular disease (180)
Career advice (1760)
Career pathing (31)
CAR-T (148)
Cell therapy (412)
Cervical cancer (21)
Clinical research (67830)
Collaboration (838)
Compensation (521)
Complete response letters (21)
COVID-19 (2712)
CRISPR (38)
C-suite (241)
Cystic fibrosis (101)
Data (2115)
Decentralized trials (2)
Denatured (27)
Depression (48)
Diabetes (269)
Diagnostics (6568)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (104)
Drug shortages (28)
Duchenne muscular dystrophy (93)
Earnings (88551)
Editorial (38)
Employer branding (21)
Employer resources (147)
Events (117044)
Executive appointments (723)
FDA (18228)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (751)
Gene editing (104)
Generative AI (25)
Gene therapy (293)
GLP-1 (755)
Government (4680)
Grass and pollen (4)
Guidances (51)
Healthcare (19900)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (114)
Indications (29)
Infectious disease (2858)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (92)
Interviews (319)
IPO (16867)
IRA (41)
Job creations (4044)
Job search strategy (1501)
Kidney cancer (10)
Labor market (38)
Layoffs (480)
Leadership (17)
Legal (8464)
Liver cancer (75)
Lung cancer (317)
Lymphoma (147)
Machine learning (5)
Management (58)
Manufacturing (300)
MASH (66)
Medical device (14358)
Medtech (14363)
Mergers & acquisitions (20199)
Metabolic disorders (703)
Multiple sclerosis (79)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (30)
Neuroscience (1972)
NextGen: Class of 2025 (6911)
Non-profit (4736)
Northern California (2593)
Now hiring (39)
Obesity (381)
Opinion (218)
Ovarian cancer (74)
Pain (86)
Pancreatic cancer (81)
Parkinson's disease (151)
Partnered (21)
Patents (230)
Patient recruitment (106)
Peanut (48)
People (60111)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21095)
Phase II (29802)
Phase III (22282)
Pipeline (1143)
Policy (135)
Postmarket research (2742)
Preclinical (8969)
Press Release (67)
Prostate cancer (103)
Psychedelics (32)
Radiopharmaceuticals (255)
Rare diseases (385)
Real estate (6303)
Recruiting (65)
Regulatory (23652)
Reports (46)
Research institute (2481)
Resumes & cover letters (359)
Rett syndrome (4)
RNA editing (4)
RSV (44)
Schizophrenia (73)
Series A (127)
Series B (83)
Service/supplier (13)
Sickle cell disease (53)
Southern California (2233)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3827)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (30)
The Weekly (31)
United States (22836)
Vaccines (711)
Venture capitalists (41)
Weight loss (259)
Women's health (37)
Worklife (15)
Date
Today (181)
Last 7 days (550)
Last 30 days (2487)
Last 365 days (33680)
2025 (9902)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57102)
2020 (55912)
2019 (48800)
2018 (36940)
2017 (33760)
2016 (33573)
2015 (39619)
2014 (33333)
2013 (28567)
2012 (30850)
2011 (31563)
2010 (29925)
Location
Africa (794)
Alabama (53)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (40971)
Australia (6753)
California (5937)
Canada (1974)
China (519)
Colorado (270)
Connecticut (281)
Delaware (142)
Europe (88758)
Florida (878)
Georgia (210)
Idaho (61)
Illinois (558)
India (25)
Indiana (312)
Iowa (10)
Japan (157)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (908)
Massachusetts (4489)
Michigan (222)
Minnesota (398)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (62)
New Hampshire (67)
New Jersey (1707)
New Mexico (29)
New York (1704)
North Carolina (1016)
North Dakota (7)
Northern California (2593)
Ohio (201)
Oklahoma (14)
Oregon (34)
Pennsylvania (1335)
Puerto Rico (11)
Rhode Island (34)
South America (1185)
South Carolina (22)
South Dakota (1)
Southern California (2233)
Tennessee (102)
Texas (889)
Utah (177)
Virginia (145)
Washington D.C. (65)
Washington State (561)
West Virginia (3)
Wisconsin (52)
735,570 Results for "medical marijuana inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
December 10, 2024
·
1 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
April 9, 2025
·
3 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
Press Releases
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
·
5 min read
Press Releases
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
April 21, 2025
·
4 min read
Press Releases
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 17, 2025
April 18, 2025
·
3 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
April 1, 2025
·
1 min read
Business
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending September 30, 2022, and provided an overview of recent operational highlights.
November 22, 2022
·
3 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
April 3, 2025
·
5 min read
1 of 73,557
Next
